Sushil Patel - 01 Apr 2026 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: REPL
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Apr 2026, 21:09:17 UTC
Prior SEC filing: 19 Dec 2025
Next SEC filing: 20 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Shawn Glidden, attorney-in-fact

Key filing fact

Sushil Patel filed Form 4 for Replimune Group, Inc. (REPL) on 07 Apr 2026.

Key facts

This page summarizes Sushil Patel's Form 4 filing for Replimune Group, Inc. (REPL).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2026, 21:09.

Change

Previous filing in this sequence was filed on 19 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001860609 Primary reporting owner

Patel Sushil

Relationship: Chief Executive Officer, Director
Address: C/O REPLIMUNE GROUP, INC., 500 UNICORN PARK DRIVE, SUITE 303, WOBURN
Signature: /s/ Shawn Glidden, attorney-in-fact
Signature date: 07 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REPL transaction

Common Stock

Award

Transaction value
Shares: +251,240
Change %: +47%
Price: $0.000000^*
Shares after: 784,816
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REPL transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +376,860
Change %
Price: $0.000000^*
Shares after: 376,860
Date: 01 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 376,860
Exercise price: $7.61
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2027 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2030, subject to the Reporting Person's continuous service to the Issuer.

Footnote F2

25% of the shares underlying this stock option vest on April 1, 2027, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter.

SEC remarks

This Form 4 is being filed late due to inadvertent administrative error.